U.S. Markets open in 5 hrs 18 mins
  • S&P Futures

    3,633.00
    +0.25 (+0.01%)
     
  • Dow Futures

    29,988.00
    -10.00 (-0.03%)
     
  • Nasdaq Futures

    12,106.50
    +30.50 (+0.25%)
     
  • Russell 2000 Futures

    1,852.20
    +0.70 (+0.04%)
     
  • Crude Oil

    45.37
    +0.46 (+1.02%)
     
  • Gold

    1,809.00
    +4.40 (+0.24%)
     
  • Silver

    23.42
    +0.12 (+0.54%)
     
  • EUR/USD

    1.1910
    +0.0014 (+0.1191%)
     
  • 10-Yr Bond

    0.8820
    0.0000 (0.00%)
     
  • Vix

    21.65
    -1.01 (-4.46%)
     
  • GBP/USD

    1.3349
    -0.0009 (-0.0708%)
     
  • USD/JPY

    104.4000
    -0.0800 (-0.0766%)
     
  • BTC-USD

    19,038.85
    +184.87 (+0.98%)
     
  • CMC Crypto 200

    377.84
    +8.09 (+2.19%)
     
  • FTSE 100

    6,441.21
    +9.04 (+0.14%)
     
  • Nikkei 225

    26,296.86
    +131.27 (+0.50%)
     

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020

Amphastar Pharmaceuticals, Inc.
·3 min read

RANCHO CUCAMONGA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its second quarter of 2020 ended June 30, 2020, after the market closes on Thursday, August 6th, 2020, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time.

To access the conference call, dial toll free (800) 708-4540, five minutes before the conference. The passcode for the conference call is 49844225.

The call can also be accessed on the Investors page on the Company’s website www.amphastar.com.

Amphastar is a specialty pharmaceutical company that primarily develops, manufactures, markets, and sells generic and proprietary injectable and inhalation products, including products with high technical barriers to market entry. Most of the Company’s products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Forward Looking Statements

All statements in this press release and in the conference call referenced above that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s expectations regarding future financial performance, backlog, sales and marketing of its products, market size and growth, the timing of FDA filings or approvals, including the DMFs of ANP, the timing of product launches, acquisitions and other matters related to its pipeline of product candidates, its share buyback program and other future events, such as the impact of the COVID-19 pandemic and related responses of business and governments to the pandemic on our operations and personnel, and on commercial activity and demand across our business operations and results of operations. These statements are not historical facts but rather are based on Amphastar’s historical performance and its current expectations, estimates, and projections regarding Amphastar’s business, operations and other similar or related factors. Words such as “may,” “might,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Amphastar’s control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Amphastar’s filings with the Securities and Exchange Commission, including in the Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 16, 2020. In particular, the extent of COVID-19’s impact on our business will depend on several factors, including the severity, duration and extent of the pandemic, as well as actions taken by governments, businesses, and consumers in response to the pandemic, all of which continue to evolve and remain uncertain at this time. You can locate these reports through the Company’s website at http://ir.amphastar.com and on the SEC’s website at www.sec.gov. The forward-looking statements in this release speak only as of the date of the release. Amphastar undertakes no obligation to revise or update information in this press release or the conference call referenced above to reflect events or circumstances in the future, even if new information becomes available or if subsequent events cause Amphastar’s expectations to change.

Contact:

William J. Peters
Chief Financial Officer
(909) 980-9484